EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review

Miao Yan, Jianghua Lin, Man Shu, Yanji Luo, Kaiyu Sun, Shaohua Yang, Xinhua Zhang iD

The Oncologist · 2023

DOI: 10.1093/oncolo/oyad168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, 2023. Verfasst von Miao Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumors are the most common mesenchymal tumors of the digestive tract, most of which are sporadic, and familial GISTs with germline mutations are rarely seen. Here, we report a 26-year-old female with a germline p. W557R mutation in exon 11 of the KIT gene. The proband and her father and sister presented with multifocal GIST and pigmented nevi. All 3 patients underwent surgery and imatinib therapy. To date, only 49 kindreds with germline KIT mutations and 6 kindreds with germline PDGFRA mutations have been reported. Summarizing the reported kindreds, the majority of familial GISTs manifest as multiple primary GISTs complicated with special clinical manifestations, including cutaneous hyperpigmentation, dysphagia, mastocytosis, inflammatory fibrous polyps, and large hands. Familial GISTs are generally thought to exhibit TKI sensitivity similar to that of sporadic GISTs with the same mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsNeoplastic Syndromes, HereditaryFemaleHumansAdultPrognosisImatinib MesylateMutationGerm-Line MutationProto-Oncogene Proteins c-kit

Stichwörter der Autor:innen

KITfamilial GISTgastrointestinal stromal tumorsgermline mutationp. W557R

Substanzen

Imatinib MesylateProto-Oncogene Proteins c-kit

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Center of Digestive Disease, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, People's Republic of China.

ORCID-Profile: Xinhua Zhang

Zitieren

APA

Yan, M., Lin, J., Shu, M., Luo, Y., Sun, K., Yang, S., & Zhang, X. (2023). Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review. The Oncologist. https://doi.org/10.1093/oncolo/oyad168

Vancouver

Yan M, Lin J, Shu M, Luo Y, Sun K, Yang S, et al. Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review. The Oncologist. 2023. doi:10.1093/oncolo/oyad168

BibTeX
@article{Yan2023,
  author = {Yan, Miao and Lin, Jianghua and Shu, Man and Luo, Yanji and Sun, Kaiyu and Yang, Shaohua and Zhang, Xinhua},
  title = {Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review},
  journal = {The Oncologist},
  year = {2023},
  doi = {10.1093/oncolo/oyad168}
}
Kostenlos starten →